{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:25:19Z","timestamp":1746339919484},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s40001-014-0062-8","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T19:08:57Z","timestamp":1415646537000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of CARMA1-BCL10-MALT1-A20-NF-\u03baB expression in T cell-acute lymphocytic leukemia"],"prefix":"10.1186","volume":"19","author":[{"given":"Yu","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S: Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008, 8: 380\u2013390. 10.1038\/nri2304","journal-title":"Nat Rev Immunol"},{"key":"62_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/15476910802129661","volume":"5","author":"JC Morris","year":"2008","unstructured":"Morris JC, Waldmann TA, Janik JE: Receptor-directed therapy of T-cell leukemias and lymphomas. J Immunotoxicol 2008, 5: 235\u2013248. 10.1080\/15476910802129661","journal-title":"J Immunotoxicol"},{"key":"62_CR3","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. N Engl J Med 2004, 350: 1535\u20131548. 10.1056\/NEJMra023001","journal-title":"N Engl J Med"},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/dna.2013.2199","volume":"33","author":"H Zheng","year":"2014","unstructured":"Zheng H, Wang X, Ma Y, Xu B, Chen S, Yang L, Wu X, Przybylski GK, Huang S, Ye T, Li Y: The TCR gammadelta repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vdelta1 and Vdelta2 T cells. DNA Cell Biol 2014, 33: 49\u201356. 10.1089\/dna.2013.2199","journal-title":"DNA Cell Biol"},{"key":"62_CR5","volume-title":"Exp Hematol Oncol","author":"HL Gimenes-Teixeira","year":"2013","unstructured":"Gimenes-Teixeira HL, Lucena-Araujo AR, Dos Santos GA, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva-Junior WA, Falcao RP, Rego EM: Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Exp Hematol Oncol 2013, 2: 10."},{"key":"62_CR6","volume-title":"Mol Cancer","author":"S Chen","year":"2013","unstructured":"Chen S, Huang X, Zheng H, Geng S, Wu X, Yang L, Weng J, Du X, Li Y: The evolution of malignant and reactive \u03b3\u03b4 + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol Cancer 2013, 12: 73."},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2005-09-3801","volume":"107","author":"A Oshiro","year":"2006","unstructured":"Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, Utsunomiya A, Masuda M, Takasu N, Nakamura S, Morishima Y, Seto M: Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia\/lymphoma. Blood 2006, 107: 4500\u20134507. 10.1182\/blood-2005-09-3801","journal-title":"Blood"},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/gcc.20677","volume":"48","author":"K Vanura","year":"2009","unstructured":"Vanura K, Vrsalovic MM, Le T, Marculescu R, Kusec R, Jager U, Nadel B: V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009, 48: 725\u2013736. 10.1002\/gcc.20677","journal-title":"Genes Chromosomes Cancer"},{"key":"62_CR9","volume-title":"Cancer Cell Int","author":"C Lin","year":"2012","unstructured":"Lin C, Zheng H, Wang C, Yang L, Chen S, Li B, Zhou Y, Tan H, Li Y: Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell Int 2012, 12: 13."},{"key":"62_CR10","volume-title":"J Hematol Oncol","author":"J Zou","year":"2013","unstructured":"Zou J, Li P, Lu F, Liu N, Dai J, Ye J, Qu X, Sun X, Ma D, Park J, Ji C: Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells. J Hematol Oncol 2013, 6: 3."},{"key":"62_CR11","volume-title":"Biomark Res","author":"N Liu","year":"2013","unstructured":"Liu N, Zhang J, Ji C: The emerging roles of Notch signaling in leukemia and stem cells. Biomark Res 2013, 1: 23."},{"key":"62_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/leu.2013.158","volume":"28","author":"B Patel","year":"2014","unstructured":"Patel B, Kang Y, Cui K, Litt M, Riberio MS, Deng C, Salz T, Casada S, Fu X, Qiu Y, Zhao K, Huang S: Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia. Leukemia 2014, 28: 349\u2013361. 10.1038\/leu.2013.158","journal-title":"Leukemia"},{"key":"62_CR13","volume-title":"Exp Hematol Oncol","author":"X Huang","year":"2012","unstructured":"Huang X, Du X, Li Y: The role of BCL11B in hematological malignancy. Exp Hematol Oncol 2012, 1: 22."},{"key":"62_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/dna.2013.2138","volume":"32","author":"Y Chen","year":"2013","unstructured":"Chen Y, Liu S, Shen Q, Zha X, Zheng H, Yang L, Chen S, Wu X, Li B, Li Y: Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells. DNA Cell Biol 2013, 32: 573\u2013581. 10.1089\/dna.2013.2138","journal-title":"DNA Cell Biol"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri2338","volume":"8","author":"M Thome","year":"2008","unstructured":"Thome M: Multifunctional roles for MALT1 in T-cell activation. Nat Rev Immunol 2008, 8: 495\u2013500. 10.1038\/nri2338","journal-title":"Nat Rev Immunol"},{"key":"62_CR16","volume-title":"Cancer Cell Int","author":"F Zhang","year":"2012","unstructured":"Zhang F, Yang L, Li Y: The role of A20 in the pathogenesis of lymphocytic malignancy. Cancer Cell Int 2012, 12: 44."},{"key":"62_CR17","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/leu.2011.101","volume":"25","author":"FC Braun","year":"2011","unstructured":"Braun FC, Grabarczyk P, Mobs M, Braun FK, Eberle J, Beyer M, Sterry W, Busse F, Schroder J, Delin M, Przybylski GK, Schmidt CA: Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia 2011, 25: 1494\u20131501. 10.1038\/leu.2011.101","journal-title":"Leukemia"},{"key":"62_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08624.x","volume":"154","author":"E Chanudet","year":"2011","unstructured":"Chanudet E, Huang Y, Zeng N, Streubel B, Chott A, Raderer M, Du MQ: TNFAIP3 abnormalities in MALT lymphoma with autoimmunity. Br J Haematol 2011, 154: 535\u2013539. 10.1111\/j.1365-2141.2011.08624.x","journal-title":"Br J Haematol"},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature07969","volume":"459","author":"M Kato","year":"2009","unstructured":"Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, Asakura Y, Muto S, Tamura A, Iio M, Akatsuka Y, Hayashi Y, Mori H, Igarashi T, Kurokawa M, Chiba S, Mori S, Ishikawa Y, Okamoto K, Tobinai K, Nakagama H, Nakahata T, Yoshino T, Kobayashi Y, Ogawa S: Frequent inactivation of A20 in B-cell lymphomas. Nature 2009, 459: 712\u2013716. 10.1038\/nature07969","journal-title":"Nature"},{"key":"62_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano A, Bhagat G, Chadburn A, Dalla-Favera R, Pasqualucci L: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459: 717\u2013721. 10.1038\/nature07968","journal-title":"Nature"},{"key":"62_CR21","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","volume":"114","author":"K Honma","year":"2009","unstructured":"Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y, Seto M: TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009, 114: 2467\u20132475. 10.1182\/blood-2008-12-194852","journal-title":"Blood"},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","volume":"113","author":"U Novak","year":"2009","unstructured":"Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F: The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 2009, 113: 4918\u20134921. 10.1182\/blood-2008-08-174110","journal-title":"Blood"},{"key":"62_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G, Klapper W, Vater I, Giefing M, Gesk S, Stanelle J, Siebert R, Kuppers R: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009, 206: 981\u2013989. 10.1084\/jem.20090528","journal-title":"J Exp Med"},{"key":"62_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ni1561","volume":"9","author":"B Coornaert","year":"2008","unstructured":"Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J, Sun L, Chen ZJ, Marynen P, Beyaert R: T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 2008, 9: 263\u2013271. 10.1038\/ni1561","journal-title":"Nat Immunol"},{"key":"62_CR25","volume-title":"Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia","author":"L Zhu","year":"2014","unstructured":"Zhu L, Zhang F, Shen Q, Chen S, Wang X, Wang L, Yang L, Wu X, Huang S, Schmidt CA, Li Y: Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia. Hematology 2014, Epub ahead of print."},{"key":"62_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","volume":"19","author":"J Ruland","year":"2003","unstructured":"Ruland J, Duncan GS, Wakeham A, Mak TW: Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003, 19: 749\u2013758. 10.1016\/S1074-7613(03)00293-0","journal-title":"Immunity"},{"key":"62_CR27","volume-title":"PLoS One","author":"S Li","year":"2012","unstructured":"Li S, Yang X, Shao J, Shen Y: Structural insights into the assembly of CARMA1 and BCL10. PLoS One 2012, 7: e42775."},{"key":"62_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/JBM.S9772","volume":"1","author":"H Hara","year":"2010","unstructured":"Hara H, Iizasa E, Nakaya M, Yoshida H: L-CBM signaling in lymphocyte development and function. J Blood Med 2010, 1: 93\u2013104. 10.2147\/JBM.S9772","journal-title":"J Blood Med"},{"key":"62_CR29","volume-title":"Cancer Cell Int","author":"X Wang","year":"2014","unstructured":"Wang X, Xu Y, Liang L, Xu Y, Wang C, Wang L, Chen S, Yang L, Wu X, Li B, Luo G, Tan H, Li W, Li Y: Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomas. Cancer Cell Int 2014, 14: 36."},{"key":"62_CR30","volume-title":"Cancer Cell Int","author":"L Shi","year":"2013","unstructured":"Shi L, Chen S, Lu Y, Wang X, Xu L, Zhang F, Yang L, Wu X, Li B, Li Y: Changes in the MALT1-A20-NF-kappaB expression pattern may be related to T cell dysfunction in AML. Cancer Cell Int 2013, 13: 37."},{"key":"62_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.it.2009.05.007","volume":"30","author":"L Vereecke","year":"2009","unstructured":"Vereecke L, Beyaert R, van Loo G: The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 2009, 30: 383\u2013391. 10.1016\/j.it.2009.05.007","journal-title":"Trends Immunol"},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1158\/1078-0432.CCR-12-3869","volume":"19","author":"L Fontan","year":"2013","unstructured":"Fontan L, Melnick A: Molecular pathways: targeting MALT1 paracaspase activity in lymphoma. Clin Cancer Res 2013, 19: 6662\u20136668. 10.1158\/1078-0432.CCR-12-3869","journal-title":"Clin Cancer Res"},{"key":"62_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature07613","volume":"458","author":"N Bidere","year":"2009","unstructured":"Bidere N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, Staudt LM, Lenardo MJ: Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature 2009, 458: 92\u201396. 10.1038\/nature07613","journal-title":"Nature"},{"key":"62_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.smim.2004.08.022","volume":"16","author":"X Lin","year":"2004","unstructured":"Lin X, Wang D: The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004, 16: 429\u2013435. 10.1016\/j.smim.2004.08.022","journal-title":"Semin Immunol"},{"key":"62_CR35","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/leu.2008.191","volume":"22","author":"SI Fujiwara","year":"2008","unstructured":"Fujiwara SI, Yamashita Y, Nakamura N, Choi YL, Ueno T, Watanabe H, Kurashina K, Soda M, Enomoto M, Hatanaka H, Takada S, Abe M, Ozawa K, Mano H: High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays. Leukemia 2008, 22: 1891\u20131898. 10.1038\/leu.2008.191","journal-title":"Leukemia"},{"key":"62_CR36","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.3747\/co.21.1798","volume":"21","author":"TC Kouroukis","year":"2014","unstructured":"Kouroukis TC, Baldassarre FG, Haynes AE, Imrie K, Reece DE, Cheung MC: Bortezomib in multiple myeloma: systematic review and clinical considerations. Curr Oncol 2014, 21: e573-e603. 10.3747\/co.21.1798","journal-title":"Curr Oncol"},{"key":"62_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.12678","volume":"164","author":"D Chaoui","year":"2014","unstructured":"Chaoui D, Bouallegue S, Arakelyan N, Genet P, Aljijakli A, Sutton L: Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma. Br J Haematol 2014, 164: 750\u2013752. 10.1111\/bjh.12678","journal-title":"Br J Haematol"},{"key":"62_CR38","volume-title":"Augmented efficacy with the combination of blockade of the NOTCH-1 pathway, Bortezomib and Romidepsin in a murine MT-1 adult T cell leukemia model","author":"P Yu","year":"2014","unstructured":"Yu P, Petrus MN, Ju W, Zhang M, Conlon KC, Nakagawa M, Maeda M, Bamford RN, Waldmann TA: Augmented efficacy with the combination of blockade of the NOTCH-1 pathway, Bortezomib and Romidepsin in a murine MT-1 adult T cell leukemia model. Leukemia 2014, Epub ahead of print."},{"key":"62_CR39","volume-title":"Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis","author":"C Mc Guire","year":"2014","unstructured":"Mc Guire C, Elton L, Wieghofer P, Staal J, Voet S, Demeyer A, Nagel D, Krappmann D, Prinz M, Beyaert R, van Loo G: Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis. J Neuroinflammation 2014, 11: 124."},{"key":"62_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan L, Yang C, Kabaleeswaran V, Volpon L, Osborne MJ, Beltran E, Garcia M, Cerchietti L, Shaknovich R, Yang SN, Fang F, Gascoyne RD, Martinez-Climent JA, Glickman JF, Borden K, Wu H, Melnick A: MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell 2012, 22: 812\u2013824. 10.1016\/j.ccr.2012.11.003","journal-title":"Cancer Cell"},{"key":"62_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbrc.2010.08.091","volume":"400","author":"C Malinverni","year":"2010","unstructured":"Malinverni C, Unterreiner A, Staal J, Demeyer A, Galaup M, Luyten M, Beyaert R, Bornancin F: Cleavage by MALT1 induces cytosolic release of A20. Biochem Biophys Res Commun 2010, 400: 543\u2013547. 10.1016\/j.bbrc.2010.08.091","journal-title":"Biochem Biophys Res Commun"},{"key":"62_CR42","volume-title":"J Hematol Oncol","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Huang H, Wei G: Novel agents and biomarkers for acute lymphoid leukemia. J Hematol Oncol 2013, 6: 40."}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-014-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40001-014-0062-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-014-0062-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-014-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:21:53Z","timestamp":1630563713000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-014-0062-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1186\/s40001-014-0062-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]},"assertion":[{"value":"4 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"62"}}